Search

Now showing items 1-2 of 2

A randomized, placebo-controlled, phase 2 trial of laquinimod in primary progressive multiple sclerosis.

Giovannoni, G; Knappertz, V; Steinerman, JR; Tansy, AP; Li, T; Krieger, S; Uccelli, A; Uitdehaag, BMJ; Montalban, X; Hartung, H-P;... (2020-08-25)

OBJECTIVE: To evaluate efficacy, safety, and tolerability of laquinimod in patients with primary progressive multiple sclerosis (PPMS). METHODS: In the randomized, double-blind, placebo-controlled, phase 2 study, ARPEGGIO ...

CSF neurofilament light chain testing as an aid to determine treatment strategies in MS.

Reyes, S; Smets, I; Holden, D; Carrillo-Loza, K; Christmas, T; Bianchi, L; Ammoscato, F; Turner, B; Marta, M; Schmierer, K;... (2020-11)

OBJECTIVE: To evaluate the use of CSF neurofilament light chain (NfL) measurements in clinical practice as well as their effect on treatment strategies and outcomes in patients with MS. METHODS: This was an observational ...